Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)
ID: PAR-20-115 • Type: Posted
Opportunity Assistant
Loading
Overview
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 2/20/20 the National Institutes of Health posted grant opportunity PAR-20-115 for Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional).
The grant will be issued under grant program 93.859 Biomedical Research and Research Training.
Timing
Posted Date
Feb. 20, 2020, 12:00 a.m. EST
Closing Date
May 27, 2022, 12:00 a.m. EDT Past Due
Last Updated
Feb. 20, 2020, 12:10 p.m. EST
Version
1
Archive Date
July 2, 2022
Eligibility
Eligible Applicants
Public and State controlled institutions of higher education
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See FOA for full eligibility details.
Award Sizing
Ceiling
$750,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 496-3405
Additional Information Site